Liaoning Chengda Biotechnology Co Ltd
SSE:688739
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.14
34.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Liaoning Chengda Biotechnology Co Ltd stock under the Base Case scenario is 34.95 CNY. Compared to the current market price of 26.71 CNY, Liaoning Chengda Biotechnology Co Ltd is Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Liaoning Chengda Biotechnology Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Liaoning Chengda Biotechnology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Liaoning Chengda Biotechnology Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Liaoning Chengda Biotechnology Co Ltd
Balance Sheet Decomposition
Liaoning Chengda Biotechnology Co Ltd
Current Assets | 7.2B |
Cash & Short-Term Investments | 5.7B |
Receivables | 1.1B |
Other Current Assets | 457.5m |
Non-Current Assets | 2.8B |
Long-Term Investments | 225.1m |
PP&E | 2B |
Intangibles | 542.3m |
Other Non-Current Assets | 90.6m |
Current Liabilities | 356.8m |
Accounts Payable | 215.1m |
Accrued Liabilities | 106.8m |
Other Current Liabilities | 35m |
Non-Current Liabilities | 125.4m |
Long-Term Debt | 15.1m |
Other Non-Current Liabilities | 110.3m |
Earnings Waterfall
Liaoning Chengda Biotechnology Co Ltd
Revenue
|
1.8B
CNY
|
Cost of Revenue
|
-326.1m
CNY
|
Gross Profit
|
1.4B
CNY
|
Operating Expenses
|
-1B
CNY
|
Operating Income
|
433m
CNY
|
Other Expenses
|
-12.7m
CNY
|
Net Income
|
420.3m
CNY
|
Free Cash Flow Analysis
Liaoning Chengda Biotechnology Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Liaoning Chengda Biotechnology Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Liaoning Chengda Biotechnology Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Liaoning Chengda Biotechnology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Liaoning Chengda Biotechnology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Liaoning Chengda Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Liaoning Chengda Biotechnology Co Ltd is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.
Dividends
Current shareholder yield for Liaoning Chengda Biotechnology Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.
Contact
IPO
Employees
Officers
The intrinsic value of one Liaoning Chengda Biotechnology Co Ltd stock under the Base Case scenario is 34.95 CNY.
Compared to the current market price of 26.71 CNY, Liaoning Chengda Biotechnology Co Ltd is Undervalued by 24%.